Drug Type Small molecule drug |
Synonyms CI 976, PD 128042, PD-128042 |
Target |
Action inhibitors |
Mechanism ACAT1 inhibitors(acetyl-CoA acetyltransferase 1 inhibitors), SOAT1 inhibitors(Acyl coenzyme A:cholesterol acyltransferase 1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC23H39NO4 |
InChIKeyWAFNZAURAWBNDZ-UHFFFAOYSA-N |
CAS Registry114289-47-3 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Atherosclerosis | Phase 2 | United States | - | - |
| Atherosclerosis | Phase 2 | - | - | |
| Hyperlipidemias | Phase 2 | United States | - | - |
| Hyperlipidemias | Phase 2 | - | - |





